Please login to the form below
Norway
This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
AZ finally gets EU nod for Veltassa rival Lokelma
It was approved in the EU last July and as of the end of 2017 had been launched in the UK, Norway and Denmark.
Latest news
-
EUSA receives European green light for kidney cancer treatment Fotivda
The go-ahead is a significant milestone for the relatively young EUSA, and means the once-daily oral can now be launched in the EU plus Norway and Iceland.
-
Shire files dry eye drug lifitegrast in Europe
Rather than submitting the marketing application to the EMA, Shire has filed lifitegrast using the decentralised procedure (DCP) to Denmark, Norway, Sweden, Finland, the UK, Germany, the Netherlands, France, Italy, Portugal,
-
A new decade of disruption: meeting the biosimilar challgenge
for infliximab in Norway, Denmark and Finland and 47% for etanercept in Norway - a move that has prompted a price reduction on the original brand.
-
Value for money healthcare - Macedonia and Estonia lead
The Netherlands and Switzerland came close to meeting all the criteria, ranking just ahead of Norway, Belgium, Iceland, Luxembourg, Germany and Finland. ... Meanwhile, prevention is still a largely unexploited resource for better health and care, but
-
Brexit - a tough pill to swallow
A Norway-type arrangement will mean less legal disruption; falling back on ordinary international trade agreements means more. ... The 'Norway option' may be best for pharma, but Norway has already signalled that this may not be available.
More from news
Approximately 1 fully matching, plus 123 partially matching documents found.
Latest Intelligence
-
The tipping point
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
-
Building a bright future
We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing
-
Pharma deals continue to slide
For example this month, Karo Pharma, Sweden acquired Weifa, Norway for $163m for product and territory complementarity.
-
2016: The year when deal-makers took stock?
product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.). ... The rate of uptake of biosimilars in Norway is exceptional, but the upward trend in other countries is still
-
Can biosimilars live up to the hype?
In Norway, biosimilars were welcomed by knowledgeable patient groups who were consulted at every stage and invited to help design the research studies.
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Gilead Sciences appoints general manager, Canada
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
-
Targovax appoints chief financial officer
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
-
Algeta execs join Targovax
Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
-
Anker Lundemose appointed CEO of Bionor Pharma
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
-
Matt Regan named AbbVie’s general manager in UK
Matt Regan named AbbVie’ s general manager in UK. Was formerly general manager of Abbott in Norway. ... Regan was formerly general manager for Abbott in Norway and will now oversee the new firm's UK presence as it establishes itself as a separate
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
-
Senior Medical Writer
-
Great salary and benefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Senior Medical Writer
-
Great salary and bebefits
-
Scientific Director
-
Great salary and bebefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
Subscribe to our email news alerts
PMHub
90TEN Healthcare
90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
